After standard treatment for a rare blood disorder stopped working, a retired Cleveland Clinic physician became one of the final patients admitted to a promising clinical trial that changed the course of her disease.
Summary from sourceAfter standard treatment for a rare blood disorder stopped working, a retired Cleveland Clinic physician became one of the final patients admitted to a promising clinical trial that changed the course of her disease.
Summary from source